England

NICE Still Opposes Adding Fampyra to NHS for England

The National Institute for Health and Care Excellence (NICE) in England is set to again recommend against adding Fampyra (fampridine) to the list of medications available to multiple sclerosis (MS) patients with walking difficulties through the countryā€™s national health service (NHS). The poor cost-effectiveness of Fampyra ā€” sold…

Mayzent Approved for Active SPMS Patients in England and Wales

Mayzent (siponimod) has become the first oral medication to be approved for people with active secondary progressive multiple sclerosis (SPMS) in England and Wales. Following this decision by England’s National Institute for Health and Care Excellence (NICE) ā€” which reversed itsĀ opinion announced in June ā€” the…

NICE Does Not Favor Adding Mayzent to NHS England for Active SPMS

TheĀ National Institute for Health and Care Excellence (NICE) is recommending againstĀ Mayzent (siponimod) as a treatment for active secondary progressive multiple sclerosis (SPMS) in the U.K., because its cost-effectiveness relative to an existing treatment for these patients is not known. NICE’s draft guidance for Mayzent is open…

NICE Approves Plegridy as RRMS Treatment Offered by NHS England

The National Institute for Health Care and Excellence (NICE) in the U.K. issued its final decision, approving the inclusion of Plegridy (peginterferon beta-1a) to treatĀ relapsing-remitting multiple sclerosis (RRMS) in England within the National Health Service (NHS). This decision follows a cost-effectiveness review done in May 2018,…

Only 47% of Primary Care Doctors in England ‘Confident’ in Treating MS Patients

General practitioners (GPs) in England lack confidence in initially assessing and referring onward people withĀ neurologicalĀ symptoms, especially those with multiple sclerosis, and believe they could benefit from betterĀ training in identifying and managing neurologicalĀ patients. One result, according toĀ a report published by theĀ Neurological Alliance,Ā titled “Neurology and primary care: improving the…